Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.
Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, Merriman TR, Moe OW, Mount DB, Sanchez Lozada LG, Stahl E, Weiner DE, Chertow GM.
Am J Kidney Dis. 2018 Jun;71(6):851-865. doi: 10.1053/j.ajkd.2017.12.009. Epub 2018 Feb 27.
PMID:29496260
Tumour lysis syndrome.
Calvo Villas JM.
Med Clin (Barc). 2019 May 17;152(10):397-404. doi: 10.1016/j.medcli.2018.10.029. Epub 2019 Jan 3.
Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway.
Liu Y, Gong S, Li K, Wu G, Zheng X, Zheng J, Lu X, Zhang L, Li J, Su Z, Liu Y, Xie J, Chen J, Li Y.
Biomed Pharmacother. 2022 Dec;156:113941. doi: 10.1016/j.biopha.2022.113941. Epub 2022 Nov 2.
PMID:36411660
Dysuricemia.
Nakayama A, Kurajoh M, Toyoda Y, Takada T, Ichida K, Matsuo H.
Biomedicines. 2023 Nov 28;11(12):3169. doi: 10.3390/biomedicines11123169.
PMID:38137389
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel.
Perissinotti AJ, Bishop MR, Bubalo J, Geyer MB, Goodrich A, Howard SC, Kula J, Mandayam S, Cairo MS, Pui CH.
Cancer Treat Rev. 2023 Nov;120:102603. doi: 10.1016/j.ctrv.2023.102603. Epub 2023 Aug 6.
PMID:37579533
Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis.
Zhao H, Chen X, Zhang L, Meng F, Zhou L, Pang X, Lu Z, Lu Y.
Med Clin North Am. 1990 Jul;74(4):859-71. doi: 10.1016/s0025-7125(16)30522-3.
PMID:2195258
Gout Medications.
[No authors listed]
2017 Jul 19. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.